Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 17 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/20/2007 First Published: 9/1/2001


1.		Phase III Randomized Study of Exatecan Mesylate and Gemcitabine Versus Gemcitabine Alone in Patients With Chemotherapy-Naive Locally Advanced or Metastatic Cancer of the Exocrine Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT031 MSKCC-02011, NCT00023972

Last Modified: 12/1/1999 First Published: 4/1/1999


2.		Phase II Study of DX-8951f in Patients with Fluorouracil-Resistant Advanced or Metastatic Adenocarinoma of the Colon or Rectum (Summary Last Modified 12/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI, Pharmaceutical / Industry				DAIICHI-8951A-PRT007 MSKCC-98103, NCI-G99-1505

Last Modified: 8/1/2001 First Published: 10/1/1999


3.		Phase II Study of DX-8951f in Patients With Hormone Refractory Prostate Cancer (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT012 SACI-IDD-99-03, SLLH-BHS-99-0020, NCT00004045

Last Modified: 4/23/2007 First Published: 8/1/1999


4.		Phase II Study of DX-8951f in Patients With Metastatic Carcinoma of the Exocrine Pancreas (Summary Last Modified 05/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT009 JHOC-99062405, MSKCC-99014, NCT00003951

Last Modified: 4/1/2002 First Published: 10/1/1999


5.		Phase II Study of DX-8951f in Women With Metastatic Adenocarcinoma of the Breast Who Have Failed Prior Therapy (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT011 MDA-ID-98308, NCT00004046

Last Modified: 9/1/2000 First Published: 10/1/1999


6.		Phase II Study of DX-8951f in Patients with Recurrent, Metastatic, or Unresectable Ovarian, Tubal, or Peritoneal Carcinoma (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT008 MDA-DM-98265, NCT00004060

Last Modified: 8/1/2001 First Published: 12/1/1999


7.		Phase II Study of DX-8951f in Patients With Hepatocellular Carcinoma (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				16 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT016 MDA-ID-99145, MSKCC-99058, UCHSC-00891, NCT00004108

Last Modified: 5/25/2006 First Published: 3/1/2000


8.		Phase II Study of DX-8951f in Women With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT015 MDA-DM-99247, NCT00004866

Last Modified: 1/29/2008 First Published: 4/1/2000


9.		Phase II Study of DX-8951f in Previously Untreated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				DAIICHI-8951E-PRT017 EU-99044, NCT00005091

Last Modified: 8/1/2001 First Published: 7/1/2000


10.		Phase II Study of DX-8951f in Patients With Biliary Tree Cancer (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				16 and over				Pharmaceutical / Industry				DAIICHI-8951A-PRT020 MDA-ID-99379, MSKCC-99110, SACI-IDD-99-31, UCHSC-00892, UTHSC-9905011256, NCT00005938

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute